FDA Approved Medical Products for:

Neonatal severe hyperparathyroidism

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Cinacalcet
Trade Name
(Manufacturer Name)
Sensipar®
(Amgen, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of hypercalcemia in adult patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo parathyroidectomy.
More Information about this product Drug Information Portal
Medline Plus Health Information